Abstract
Purpose
Patients with Turner syndrome (TS) are frequently affected by congenital as well as acquired cardiovascular diseases. The aim of the study was to evaluate the blood pressure, the endothelial function (FMD) and the intima media thickness (IMT) at the level of the common carotid arteries in a group of girls and young women with TS in comparison to healthy controls.
Methods
We evaluated 40 unselected TS patients, with a mean age of 18.6 ± 0.9 years and 103 age matched healthy subjects. Main outcome measures: blood pressure, FMD and IMT.
Results
No differences were found in systolic and diastolic blood pressure between TS patients and controls. FMD was higher in TS than in controls (14.2 ± 1.4 vs 11.4 ± 0.3 %, p = 0.005) whereas IMT was not statistically different in the two study groups (0.54 ± 0.04 vs 0.57 ± 0.01 mm). However, in TS patients an inverse correlation was found between FMD and both age (−0.03 ± 0.01, p = 0.003) and years of estrogen therapy (−0.72 ± 0.31, p < 0.03), whereas a positive correlation was found between IMT and age (R 2 = 0.35, p < 0.0001) and estrogen therapy duration (R 2 = 0.65, p < 0.0001), suggesting a clear tendency toward a premature decrease in FMD and premature increase in IMT compared to controls.
Conclusions
Young TS patients show an arterial wall which is functionally and structurally comparable or betterthan controls. They show, however, a premature derangement of the arterial function and structure, which seems to be partly influenced by age and duration of oestrogen treatment.
Similar content being viewed by others
References
Price WH, Clayton JF, Collyer S, De Mey R, Wilson J (1986) Mortality ratios, life expectancy, and causes of death in patients with Turner’s syndrome. J Epidemiol Community Health 40(2):97–102
Donadille B, Rousseau A, Zenaty D, Cabrol S, Courtillot C, Samara-Boustani D, Salenave S, Monnier-Cholley L, Meuleman C, Jondeau G, Iserin L, Duranteau L, Cabanes L, Bourcigaux N, Bonnet D, Bouchard P, Chanson P, Polak M, Touraine P, Lebouc Y, Carel JC, Leger J, Christin-Maitre S (2012) Cardiovascular findings and management in Turner syndrome: insights from a French cohort. Eur J Endocrinol Eur Fed Endocr Soc 167(4):517–522. doi:10.1530/EJE-12-0434
Mortensen KH, Andersen NH, Gravholt CH (2012) Cardiovascular phenotype in Turner syndrome—integrating cardiology, genetics, and endocrinology. Endocr Rev 33(5):677–714. doi:10.1210/er.2011-1059
Elsheikh M, Dunger DB, Conway GS, Wass JA (2002) Turner’s syndrome in adulthood. Endocr Rev 23(1):120–140. doi:10.1210/edrv.23.1.0457
Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH (2006) Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 91(10):3897–3902. doi:10.1210/jc.2006-0558
Nathwani NC, Unwin R, Brook CG, Hindmarsh PC (2000) Blood pressure and Turner syndrome. Clin Endocrinol 52(3):363–370
Gravholt CH, Hansen KW, Erlandsen M, Ebbehoj E, Christiansen JS (2006) Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome. J Hypertens 24(2):353–360. doi:10.1097/01.hjh.0000200509.17947.0f
Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA (2008) Mortality in women with Turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab 93(12):4735–4742. doi:10.1210/jc.2008-1049
Gravholt CH, Juul S, Naeraa RW, Hansen J (1998) Morbidity in Turner syndrome. J Clin Epidemiol 51(2):147–158
Saenger P (1993) Clinical review 48: the current status of diagnosis and therapeutic intervention in Turner’s syndrome. J Clin Endocrinol Metab 77(2):297–301. doi:10.1210/jcem.77.2.8345029
Baguet JP, Douchin S, Pierre H, Rossignol AM, Bost M, Mallion JM (2005) Structural and functional abnormalities of large arteries in the Turner syndrome. Heart 91(11):1442–1446. doi:10.1136/hrt.2004.048371
Ostberg JE, Donald AE, Halcox JP, Storry C, McCarthy C, Conway GS (2005) Vasculopathy in Turner syndrome: arterial dilatation and intimal thickening without endothelial dysfunction. J Clin Endocrinol Metab 90(9):5161–5166. doi:10.1210/jc.2005-0677
van den Berg J, Bannink EM, Wielopolski PA, Pattynama PM, de Muinck Keizer-Schrama SM, Helbing WA (2006) Aortic distensibility and dimensions and the effects of growth hormone treatment in the turner syndrome. Am J Cardiol 97(11):1644–1649. doi:10.1016/j.amjcard.2005.12.058
Egashira K (2002) Clinical importance of endothelial function in arteriosclerosis and ischemic heart disease. Circ J Off J Jpn Circ Soc 66(6):529–533
Kinlay S, Ganz P (1997) Role of endothelial dysfunction in coronary artery disease and implications for therapy. Am J Cardiol 80(9A):11I–16I
Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115(4):459–467. doi:10.1161/CIRCULATIONAHA.106.628875
Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, Cerutti F, Gargantini L, Greggio N, Tonini G, Cicognani A (2006) Italian cross-sectional growth charts for height, weight and BMI (2–20 years). J Endocrinol Invest 29(7):581–593
National High Blood Pressure Education Program Working Group on High Blood Pressure in C, Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114(2):555–576
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419
Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85(7):2402–2410. doi:10.1210/jcem.85.7.6661
Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R, International Brachial Artery Reactivity Task F (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39(2):257–265
Sagi L, Zuckerman-Levin N, Gawlik A, Ghizzoni L, Buyukgebiz A, Rakover Y, Bistritzer T, Admoni O, Vottero A, Baruch O, Fares F, Malecka-Tendera E, Hochberg Z (2007) Clinical significance of the parental origin of the X chromosome in Turner syndrome. J Clin Endocrinol Metab 92(3):846–852. doi:10.1210/jc.2006-0158
Mortensen KH, Hansen KW, Erlandsen M, Christiansen JS, Gravholt CH (2009) Ambulatory arterial stiffness index in Turner syndrome: the impact of sex hormone replacement therapy. Horm Res 72(3):184–189. doi:10.1159/000232495
Mortensen KH, Andersen NH, Hjerrild BE, Horlyck A, Stochholm K, Hojbjerg Gravholt C (2012) Carotid intima-media thickness is increased in Turner syndrome: multifactorial pathogenesis depending on age, blood pressure, cholesterol and oestrogen treatment. Clin Endocrinol 77(6):844–851. doi:10.1111/j.1365-2265.2012.04337.x
Abdu TA, Elhadd TA, Buch H, Barton D, Neary R, Clayton RN (2004) Recombinant GH replacement in hypopituitary adults improves endothelial cell function and reduces calculated absolute and relative coronary risk. Clin Endocrinol 61(3):387–393. doi:10.1111/j.1365-2265.2004.02109.x
Borson-Chazot F, Serusclat A, Kalfallah Y, Ducottet X, Sassolas G, Bernard S, Labrousse F, Pastene J, Sassolas A, Roux Y, Berthezene F (1999) Decrease in carotid intima-media thickness after 1 year growth hormone (GH) treatment in adults with GH deficiency. J Clin Endocrinol Metab 84(4):1329–1333. doi:10.1210/jcem.84.4.5595
Caidahl K, Eden S, Bengtsson BA (1994) Cardiovascular and renal effects of growth hormone. Clin Endocrinol 40(3):393–400
Radetti G, Crepaz R, Milanesi O, Paganini C, Cesaro A, Rigon F, Pitscheider W (2001) Cardiac performance in Turner’s syndrome patients on growth hormone therapy. Horm Res 55(5):240–244
Elsheikh M, Bird R, Casadei B, Conway GS, Wass JA (2000) The effect of hormone replacement therapy on cardiovascular hemodynamics in women with Turner’s syndrome. J Clin Endocrinol Metab 85(2):614–618. doi:10.1210/jcem.85.2.6384
Ostberg JE, Storry C, Donald AE, Attar MJ, Halcox JP, Conway GS (2007) A dose-response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism. Clin Endocrinol 66(4):557–564. doi:10.1111/j.1365-2265.2007.02772.x
Ahimastos AA, Formosa M, Dart AM, Kingwell BA (2003) Gender differences in large artery stiffness pre- and post-puberty. J Clin Endocrinol Metab 88(11):5375–5380. doi:10.1210/jc.2003-030722
Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM (2002) Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the women’s health initiative observational study. JAMA 288(8):980–987
Rosendaal FR, Vessey M, Rumley A, Daly E, Woodward M, Helmerhorst FM, Lowe GD (2002) Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis. Br J Haematol 116(4):851–854
Salpeter SR, Walsh JM, Greyber E, Ormiston TM, Salpeter EE (2004) Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med 19(7):791–804. doi:10.1111/j.1525-1497.2004.30281.x
Zhu X, Bonet B, Gillenwater H, Knopp RH (1999) Opposing effects of estrogen and progestins on LDL oxidation and vascular wall cytotoxicity: implications for atherogenesis. Proc Soc Exp Biol Med Soc Exp Biol Med 222(3):214–221
Sweetland S, Beral V, Balkwill A, Liu B, Benson VS, Canonico M, Green J, Reeves GK, Million Women Study C (2012) Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. JTH 10(11):2277–2286. doi:10.1111/j.1538-7836.2012.04919.x
Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Aanstoot HJ, Drop SL (2000) Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose—response study. Dutch Advisory Group on Growth Hormone. J Clin Endocrinol Metab 85(2):769–775. doi:10.1210/jcem.85.2.6334
Radetti G, Pasquino B, Gottardi E, Boscolo Contadin I, Aimaretti G, Rigon F (2004) Insulin sensitivity in Turner’s syndrome: influence of GH treatment. Eur J Endocrinol Eur Fed Endocr Soc 151(3):351–354
Sengstock DM, Vaitkevicius PV, Supiano MA (2005) Arterial stiffness is related to insulin resistance in nondiabetic hypertensive older adults. J Clin Endocrinol Metab 90(5):2823–2827. doi:10.1210/jc.2004-1686
Kasayama S, Saito H, Mukai M, Koga M (2005) Insulin sensitivity independently influences brachial-ankle pulse-wave velocity in non-diabetic subjects. Diabet Med J Br Diabet Assoc 22(12):1701–1706. doi:10.1111/j.1464-5491.2005.01718.x
Conflict of interest
I certify that there is no actual or potential conflict of interest in relation to this article for all authors.
Ethical approval
All the research has been performed according to the Ethical Standards involving human participants and /or animals.
Informed consent
An informed consent was obtained from the patients and the protocol approved by the local review board.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Radetti, G., Mazzanti, L., Di Somma, C. et al. Evaluation of function and structure of arterial wall in girls and young women with Turner syndrome. J Endocrinol Invest 38, 963–970 (2015). https://doi.org/10.1007/s40618-015-0268-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-015-0268-9